Cash cost of the wait: management is funding a defined waiting period whose end is already scheduled
The model's full reasoning — Q4 2021 call → NOWe need to determine if the company is currently living through a defined waiting period it is paying for out of its own pocket, with a specific near-dated event that ends the wait, and the cost is real and currently landing in results. From the transcript, management discusses several things: capital investment in new yarn texturing machinery (EvoCooler) over the next 3 years. They mention that they are increasing capital investment to outfit plants with new equipment. They say it will give efficiencies, more capacity, etc. They also mention that they are in the initial stages of getting those first machines into operations, and it won't be until the back half of FY '22 that they start to see some benefit. So they are paying for equipment now, installing it, and the benefit comes later. That seems like a waiting period. But is it a "defined waiting period" with a specific near-dated event? They say they will continue installation during first half of FY '22, and start to see benefit in back half of FY '22. So the benefit arrives within the coming year. The cost is capital expenditure, which is not an earnings cost but a cash cost. However, the question says "real, ongoing cash or earnings cost" - capital expenditure is cash cost. But is it "currently landing in the results"? Capital expenditure doesn't hit the income statement directly, but depreciation will later. However, they also mention that they are paying for it now, and the benefit hasn't arrived yet. But is this a "waiting period" that is the company's main current work? They talk about it as a priority, but they also talk about other things like managing inflation, pricing, etc. The main theme of the call is about strong results, recovery, and guidance. The capital investment is mentioned as a future plan, not as a current burden. They say "we are planning to continue these investments during fiscal year 2022" - so it's ongoing, not a defined interval with a specific end event. Also, the benefit is not a single event but a gradual ramp. The question asks for a specific, near-dated event that ends the wait. Here, the benefit is expected in the back half of FY '22, but that's not a single event; it's a period. Also, the cost is capital expenditure, which is not an earnings cost but an investment.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| LILA | Liberty Latin America Ltd. | Q4 2023 | 2024-02-23 | C |
| SBS | Companhia de Saneamento Básico do Estado | Q3 2023 | 2023-11-10 | C+ |
| QTRX | Quanterix Corporation | Q3 2023 | 2023-11-07 | B |
| APPS | Digital Turbine, Inc. | Q1 2024 | 2023-08-08 | D |
| PRPH | ProPhase Labs, Inc. | Q1 2023 | 2023-05-11 | F |
| CDE | Coeur Mining, Inc. | Q1 2023 | 2023-05-11 | C+ |
| SOL | ReneSola Ltd | Q3 2022 | 2022-12-01 | C+ |
| FLL | Full House Resorts, Inc. | Q3 2022 | 2022-11-07 | B |
| EHTH | eHealth, Inc. | Q2 2021 | 2021-07-29 | F |
| IRT | Independence Realty Trust, Inc. | Q2 2018 | 2018-08-02 | B |
| YUM | Yum! Brands, Inc. | Q2 2018 | 2018-08-02 | C |
| IBTX | Independent Bank Group, Inc. | Q3 2017 | 2017-10-24 | A |
| FLEX | Flex Ltd. | Q1 2018 | 2017-07-28 | F |
| DAN | Dana Incorporated | Q1 2017 | 2017-05-02 | B |
SBS · Q3 2023 → YESThe question is whether management describes the company as currently living through a defined waiting period it's paying for out of its own pocket. YES The transcript shows management describing the company as currently bearing real, ongoing cash costs (salaries, consulting, transition work) for the IDP/restructuring program whose benefits (full expense reduction, shared-services center operational) are not yet realized. The far side is a specific, near-dated event: full 3.7% staff reduction and shared-services center operational by mid-2024 (July 2024 for full benefit), with the program already in motion and on schedule. Management frames this as the main current work, not a setback, and treats the costs as self-funded. This meets all three conditions.
EHTH · Q2 2021 → YESThe question is whether management describes the company as currently living through a defined waiting period it is paying for out of its own pocket. YES The transcript shows management describing the company as currently living through a defined waiting period for the AEP, paying for it out of its own pocket through heavy investments in internal agents and quality initiatives. They hired agents early, many still in training with lower productivity, and are bearing the cost of additional training and customer service expansion in Q3. This is framed as a chosen investment to improve enrollment quality and prepare for the fourth-quarter AEP, not an apology or external issue.
YUM · Q2 2018 → YESThe question is whether management describes the company as currently living through a defined waiting period it is paying for out of its own pocket. YES The transcript shows management describing a clear, self-funded transition cost tied to the refranchising effort. They explicitly call out the “timing mismatch between G&A savings and refranchising” as one of the four items weighing on Q2 core operating profit, and they quantify the full-year headwind at 6 7 percentage points. This is presented as a real, ongoing drag on current results while they complete the shift to 98 % franchised by year-end 2018 and reach the 1.7 % G&A run-rate target in 2019.